These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 21160084

  • 1. Aldosterone antagonists in heart failure.
    Guglin M, Kristof-Kuteyeva O, Novotorova I, Pratap P.
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084
    [Abstract] [Full Text] [Related]

  • 2. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Jun; 5(5):354-63. PubMed ID: 14503934
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of aldosterone receptor antagonists in the management of heart failure: an update.
    Nagarajan V, Chamsi-Pasha M, Tang WH.
    Cleve Clin J Med; 2012 Sep; 79(9):631-9. PubMed ID: 22949344
    [Abstract] [Full Text] [Related]

  • 5. [The EMPHASIS-HF study].
    Boccanelli A, Agostoni P.
    G Ital Cardiol (Rome); 2011 May; 12(5):315-8. PubMed ID: 21593949
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
    Capuano A, Scavone C, Vitale C, Sportiello L, Rossi F, Rosano GM, Coats AJ.
    Int J Cardiol; 2015 Dec 01; 200():15-9. PubMed ID: 26404747
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blocking aldosterone in heart failure.
    Shafiq MM, Miller AB.
    Ther Adv Cardiovasc Dis; 2009 Oct 01; 3(5):379-85. PubMed ID: 19661156
    [Abstract] [Full Text] [Related]

  • 16. New treatment option for heart failure patients: eplerenone.
    Southworth MR, Cavallari LH.
    J Cardiovasc Nurs; 2004 Oct 01; 19(6):390-5. PubMed ID: 15529060
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone.
    Lainscak M, Pelliccia F, Rosano G, Vitale C, Schiariti M, Greco C, Speziale G, Gaudio C.
    Int J Cardiol; 2015 Dec 01; 200():25-9. PubMed ID: 26404748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.